According to AlphaMoat, in the latest data month Toursynbio (toursynbio.com) received 0 monthly visits — ranked #0 of 17,407 AI websites with traffic data, and #0 of 3,173 in Industry Services.
What is Toursynbio
Toursynbio (Tushen Zhihé) is an AI-native biopharma company that advances drug discovery into drug creation by combining AI with automated experimentation, building an autonomous AI biopharma base and redefining how biologics are developed.
- 01TourSynBioClaw is a scientific-superintelligence agent platform for biologics that drives the closed-loop R&D of molecular design, wet-lab validation, and data feedback
- 02ProteinNova and ProteinEngine support site-directed mutagenesis, enzyme engineering, de novo design, and antibody structure prediction
- 03it integrates AI compute with automated lab infrastructure
- 04antibody design to functional validation takes about 1.5 months at fastest
- 05it has advanced 16 antibody projects through PCC-stage validation and tackled hard targets such as GPCR
It offers platform and R&D services to pharma companies and R&D partners; the site does not publish a standard price list and requires partnership discussions, and lists no explicit product price figures.
Popular in Industry Services
Data month: — · Visit figures are third-party traffic estimates aggregated monthly — best for scale and trends. Multiple domains of the same product are merged. See methodology.